Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE (ABBV)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/21/2018 05/22/2018 05/23/2018 05/24/2018 05/25/2018 Date
106.23(c) 106.23(c) 105.6(c) 103.14(c) 101.08(c) Last
5 797 323 9 456 794 12 816 604 13 164 507 21 600 021 Volume
+0.24% 0.00% -0.59% -2.33% -2.00% Change
More quotes
Financials (USD)
Sales 2018 32 909 M
EBIT 2018 14 381 M
Net income 2018 10 846 M
Debt 2018 28 639 M
Yield 2018 3,53%
Sales 2019 34 665 M
EBIT 2019 16 106 M
Net income 2019 11 924 M
Debt 2019 23 254 M
Yield 2019 4,00%
P/E ratio 2018 14,72
P/E ratio 2019 13,09
EV / Sales2018 5,74x
EV / Sales2019 5,30x
Capitalization 160 B
More Financials
Company
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products.It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology;... 
Sector
Pharmaceuticals
Calendar
06/01 | 10:45pmPresentation
More about the company
Surperformance© ratings of AbbVie
Trading Rating : Investor Rating :
More Ratings
Latest news on ABBVIE
05/26ABBVIE : eyes Imbruvica expansion in CLL as Gazyva pairing hits its marks
AQ
05/26ABBVIE : trial backs chemo-free Imbruvica combo regimen
AQ
05/24ABBVIE : IMBRUVICA® (ibrutinib) Plus GAZYVA® (obinutuzumab) Phase 3 iLLUMINATE T..
PU
05/23CYTOMX THERAPEUTICS : Announces FDA Clearance of Investigational New Drug Applic..
AQ
05/23ABBVIE : Donates $100 Million to Strengthen Access to Healthcare, Housing for Hu..
AQ
05/22ABBVIE : to donate $100M for health, housing in Puerto Rico
AQ
05/22ABBVIE : Donates $100 Million to Strengthen Access to Healthcare, Housing for Hu..
PU
05/22ABBVIE : to Present at the Jefferies 2018 Global Healthcare Conference
PR
05/22ABBVIE : to Show Progress and Growth in Oncology Research at the American Societ..
AQ
05/21ABBVIE INC. (NYSE : ABBV) Files An 8-K Entry into a Material Definitive Agreemen..
AQ
More news
Sector news : Specialty & Advanced Pharmaceuticals
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
05/25GRAIN HIGHLIGHTS : Top Stories of the Day
DJ
05/25LIVESTOCK HIGHLIGHTS : Top Stories of the Day
DJ
05/25ADRs End Lower; Major Oil Companies, Acorn International, and AstraZeneca Tra..
DJ
05/25Bayer cuts Monsanto synergy target by $300 million due to divestments
RE
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on ABBVIE 
ABBVIE  - 2015
A likely recovery
BUY
More Strategies
Latest Tweets
09:20a$AAPL #APPLE $ABBV $ADM $ALLE $AM $AMGP $AMT $ANDX $AOS $APD $APTS $AQN $AVGO.. 
01:15a$BMRN $VSTM $RVNC $COTQF $TNXP $ABBV $TEVA $BMY $AMRN $IDRA $ACRX  
05/26AbbVie $ABBV Downgraded by Goldman Sachs Group to Buy  
05/26Traders Buy AbbVie $ABBV on Weakness Following Analyst Downgrade  
05/25? ACTIVE LINES FOR NEXT WEEK (6/1/18): $BAC $AMD $AAPL $BABA $GE $QCOM $TRIP ..
11
More tweets
Qtime:268
News from SeekingAlpha
03:20aDIVIDEND SENSEI'S PORTFOLIO UPDATE 3 : To Get Rich First, You Need To Do One Ver.. 
05/27YOUR DAILY PHARMA SCOOP : ACRX NDA Accepted, BioMarin Gets Approval, Genmab Fail.. 
05/263 THINGS IN BIOTECH, MAY 25 : A CLL Game Changer 
05/25Market Values Stocks Incorrectly In The Short Term - Cramer's Mad Money (5/24.. 
05/24'Safer' Dividend Healthcare Top WallStar Gainers Are Gilead, Sanofi, Amerisou.. 
Chart ABBVIE
Duration : Period :
AbbVie Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Technical analysis trends ABBVIE
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 116 $
Spread / Average Target 15%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Azita Saleki-Gerhardt Senior Vice President-Operations
William J. Chase Chief Financial Officer & Executive Vice President
Michael E. Severino Chief Scientific Officer & Executive VP
Robert J. Alpern Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE4.52%160 402
MERCK KGAA-4.89%12 852
KYOWA HAKKO KIRIN CO LTD1.13%11 838
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD90.00%11 337
JAZZ PHARMACEUTICALS PLC22.55%9 901
CONVATEC GROUP9.59%5 929